Dimensional Fund Advisors
MBX

Dimensional Fund Advisors’s MBX Biosciences MBX Stock Holding History

Dimensional Fund Advisors’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9M Buy
233,700
+186,947
+400% +$6.53M ﹤0.01% 2200
2026
Q1 		$1.4M Buy
+46,753
New +$1.59M ﹤0.01% 2777

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Dimensional Fund Advisors's MBX Position: Q2 2026 in Review

Dimensional Fund Advisors increased its MBX Biosciences (MBX) stake by 400% in Q2 2026, buying an estimated $6.53M and bringing the position to 233,700 shares worth $12.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2200.

Dimensional Fund Advisors first reported a position in MBX in Q1 2026 and has held it in 2 quarters since. 173 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • Dimensional Fund Advisors held 233,700 shares of MBX Biosciences worth $12.9M as of Q2 2026.
  • Dimensional Fund Advisors bought 186,947 MBX Biosciences shares in Q2 2026, an estimated $6.53M.
  • MBX Biosciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2200 holding.
  • Dimensional Fund Advisors first reported a position in MBX Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 173 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.